The bill authorizes prescribers to prescribe medications for off-label indications and allows pharmacists to dispense these medications, provided they are within their scope of practice and based on a valid prescription order. It defines "off-label indication" as drug treatments for conditions not specified in the FDA-approved labeling. The bill also stipulates that prescribers and pharmacists will not face disciplinary action from health-related licensing boards solely for prescribing or dispensing medications for off-label use, with specific exceptions for certain controlled substances and procedures related to gender transition or abortion.

Additionally, the bill includes provisions for severability, ensuring that if any part of the legislation is deemed unconstitutional, the remaining sections will still be enforceable. It mandates that relevant state boards, including those for medicine, dentistry, optometry, nursing, and pharmacy, adopt necessary rules for implementation. The act is set to take effect on July 1, 2025.